{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:30:16Z","timestamp":1791354616596,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T00:00:00Z","timestamp":1428278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T00:00:00Z","timestamp":1428278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/nm.3821","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T17:39:45Z","timestamp":1428428385000},"page":"498-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network"],"prefix":"10.1038","volume":"21","author":[{"given":"Cl\u00e9mence D","family":"C\u00f4t\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany A","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A","family":"Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Zadeh-Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Daljeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna M","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice M","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony K T","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,6]]},"reference":[{"key":"BFnm3821_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature05354","volume":"444","author":"JA Baur","year":"2006","unstructured":"Baur, J.A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337\u2013342 (2006).","journal-title":"Nature"},{"key":"BFnm3821_CR2","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db10-0987","volume":"60","author":"CM Knight","year":"2011","unstructured":"Knight, C.M. et al. Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 60, 2691\u20132700 (2011).","journal-title":"Diabetes"},{"key":"BFnm3821_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109\u20131122 (2006).","journal-title":"Cell"},{"key":"BFnm3821_CR4","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1210\/en.2009-0528","volume":"150","author":"G Ramadori","year":"2009","unstructured":"Ramadori, G. et al. Central administration of resveratrol improves diet-induced diabetes. Endocrinology 150, 5326\u20135333 (2009).","journal-title":"Endocrinology"},{"key":"BFnm3821_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bcp.2008.11.027","volume":"77","author":"L Rivera","year":"2009","unstructured":"Rivera, L., Moron, R., Zarzuelo, A. & Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 77, 1053\u20131063 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm3821_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","volume":"14","author":"S Timmers","year":"2011","unstructured":"Timmers, S. et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14, 612\u2013622 (2011).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","volume":"15","author":"NL Price","year":"2012","unstructured":"Price, N.L. et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 15, 675\u2013690 (2012).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park, S.J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421\u2013433 (2012).","journal-title":"Cell"},{"key":"BFnm3821_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.phymed.2012.12.012","volume":"20","author":"L Liang","year":"2013","unstructured":"Liang, L. et al. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4\u2032-tri-O-acetylresveratrol in rats. Phytomedicine 20, 558\u2013563 (2013).","journal-title":"Phytomedicine"},{"key":"BFnm3821_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/sj.bjc.6601568","volume":"90","author":"S Sale","year":"2004","unstructured":"Sale, S. et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4\u2032-tetramethoxystilbene. Br. J. Cancer 90, 736\u2013744 (2004).","journal-title":"Br. J. Cancer"},{"key":"BFnm3821_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cmet.2007.08.014","volume":"6","author":"C Sun","year":"2007","unstructured":"Sun, C. et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6, 307\u2013319 (2007).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.nutres.2012.06.003","volume":"32","author":"JK Bhatt","year":"2012","unstructured":"Bhatt, J.K., Thomas, S. & Nanjan, M.J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 32, 537\u2013541 (2012).","journal-title":"Nutr. Res."},{"key":"BFnm3821_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/S0007114511000316","volume":"106","author":"P Brasny\u00f3","year":"2011","unstructured":"Brasny\u00f3, P. et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 106, 383\u2013389 (2011).","journal-title":"Br. J. Nutr."},{"key":"BFnm3821_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/gerona\/glr235","volume":"67","author":"JP Crandall","year":"2012","unstructured":"Crandall, J.P. et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1307\u20131312 (2012).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"BFnm3821_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2008.08.014","volume":"8","author":"AS Banks","year":"2008","unstructured":"Banks, A.S. et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333\u2013341 (2008).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1474-9726.2007.00335.x","volume":"6","author":"L Bordone","year":"2007","unstructured":"Bordone, L. et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759\u2013767 (2007).","journal-title":"Aging Cell"},{"key":"BFnm3821_CR17","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.1073\/pnas.0802917105","volume":"105","author":"PT Pfluger","year":"2008","unstructured":"Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M. & Tschop, M.H. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. USA 105, 9793\u20139798 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3821_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cmet.2011.06.014","volume":"14","author":"G Ramadori","year":"2011","unstructured":"Ramadori, G. et al. SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab. 14, 301\u2013312 (2011).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR19","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1231097","volume":"339","author":"BP Hubbard","year":"2013","unstructured":"Hubbard, B.P. et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339, 1216\u20131219 (2013).","journal-title":"Science"},{"key":"BFnm3821_CR20","doi-asserted-by":"publisher","first-page":"205ra133","DOI":"10.1126\/scitranslmed.3005870","volume":"5","author":"KR Patel","year":"2013","unstructured":"Patel, K.R. et al. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci. Transl. Med. 5, 205ra133 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFnm3821_CR21","doi-asserted-by":"publisher","first-page":"e2020","DOI":"10.1371\/journal.pone.0002020","volume":"3","author":"R Firestein","year":"2008","unstructured":"Firestein, R. et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE 3, e2020 (2008).","journal-title":"PLoS ONE"},{"key":"BFnm3821_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nm.2745","volume":"18","author":"DM Breen","year":"2012","unstructured":"Breen, D.M. et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat. Med. 18, 950\u2013955 (2012).","journal-title":"Nat. Med."},{"key":"BFnm3821_CR23","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1074\/jbc.O114.556068","volume":"289","author":"CD C\u00f4t\u00e9","year":"2014","unstructured":"C\u00f4t\u00e9, C.D., Zadeh-Tahmasebi, M., Rasmussen, B.A., Duca, F.A. & Lam, T.K. Hormonal signaling in the gut. J. Biol. Chem. 289, 11642\u201311649 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnm3821_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cmet.2013.11.014","volume":"19","author":"BA Rasmussen","year":"2014","unstructured":"Rasmussen, B.A. et al. Jejunal leptin-PI3K signaling lowers glucose production. Cell Metab. 19, 155\u2013161 (2014).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/nature06852","volume":"452","author":"PY Wang","year":"2008","unstructured":"Wang, P.Y. et al. Upper intestinal lipids trigger a gut\u2013brain\u2013liver axis to regulate glucose production. Nature 452, 1012\u20131016 (2008).","journal-title":"Nature"},{"key":"BFnm3821_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature12709","volume":"503","author":"MW Schwartz","year":"2013","unstructured":"Schwartz, M.W. et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 503, 59\u201366 (2013).","journal-title":"Nature"},{"key":"BFnm3821_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers, J.T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature 434, 113\u2013118 (2005).","journal-title":"Nature"},{"key":"BFnm3821_CR28","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.2337\/diabetes.50.12.2786","volume":"50","author":"J Wang","year":"2001","unstructured":"Wang, J. et al. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50, 2786\u20132791 (2001).","journal-title":"Diabetes"},{"key":"BFnm3821_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur, J.A. & Sinclair, D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493\u2013506 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm3821_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db09-0482","volume":"59","author":"JH Um","year":"2010","unstructured":"Um, J.H. et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554\u2013563 (2010).","journal-title":"Diabetes"},{"key":"BFnm3821_CR31","doi-asserted-by":"crossref","unstructured":"Duca, F.A. et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. (2015) (in the press).","DOI":"10.1038\/nm.3787"},{"key":"BFnm3821_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1053\/j.gastro.2011.12.053","volume":"142","author":"BA Rasmussen","year":"2012","unstructured":"Rasmussen, B.A. et al. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 142, 834\u2013843.e3 (2012).","journal-title":"Gastroenterology"},{"key":"BFnm3821_CR33","doi-asserted-by":"publisher","first-page":"34098","DOI":"10.1074\/jbc.M113.516880","volume":"288","author":"PC Chen","year":"2013","unstructured":"Chen, P.C., Kryukova, Y.N. & Shyng, S.L. Leptin regulates KATP channel trafficking in pancreatic beta-cells by a signaling mechanism involving AMP-activated protein kinase (AMPK) and cAMP-dependent protein kinase (PKA). J. Biol. Chem. 288, 34098\u201334109 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnm3821_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai, A. et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434, 1026\u20131031 (2005).","journal-title":"Nature"},{"key":"BFnm3821_CR35","doi-asserted-by":"publisher","first-page":"12121","DOI":"10.1073\/pnas.0812547106","volume":"106","author":"VT Samuel","year":"2009","unstructured":"Samuel, V.T. et al. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc. Natl. Acad. Sci. USA 106, 12121\u201312126 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3821_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2337\/db12-0975","volume":"62","author":"MM Poulsen","year":"2013","unstructured":"Poulsen, M.M. et al. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186\u20131195 (2013).","journal-title":"Diabetes"},{"key":"BFnm3821_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmet.2012.09.015","volume":"16","author":"J Yoshino","year":"2012","unstructured":"Yoshino, J. et al. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16, 658\u2013664 (2012).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR38","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056\u20131060 (2009).","journal-title":"Nature"},{"key":"BFnm3821_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.devcel.2008.02.004","volume":"14","author":"M Fulco","year":"2008","unstructured":"Fulco, M. et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14, 661\u2013673 (2008).","journal-title":"Dev. Cell"},{"key":"BFnm3821_CR40","first-page":"2959","volume":"118","author":"H Ono","year":"2008","unstructured":"Ono, H. et al. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J. Clin. Invest. 118, 2959\u20132968 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm3821_CR41","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1053\/j.gastro.2011.06.042","volume":"141","author":"A Kokorovic","year":"2011","unstructured":"Kokorovic, A. et al. Duodenal mucosal protein kinase C-\u03b4 regulates glucose production in rats. Gastroenterology 141, 1720\u20131727 (2011).","journal-title":"Gastroenterology"},{"key":"BFnm3821_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cmet.2012.09.005","volume":"16","author":"BM Filippi","year":"2012","unstructured":"Filippi, B.M., Yang, C.S., Tang, C. & Lam, T.K. Insulin activates Erk1\/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 16, 500\u2013510 (2012).","journal-title":"Cell Metab."},{"key":"BFnm3821_CR43","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/sj.emboj.7600667","volume":"24","author":"K Sakamoto","year":"2005","unstructured":"Sakamoto, K. et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24, 1810\u20131820 (2005).","journal-title":"EMBO J."},{"key":"BFnm3821_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0014-5793(95)00172-6","volume":"361","author":"S Dale","year":"1995","unstructured":"Dale, S., Wilson, W.A., Edelman, A.M. & Hardie, D.G. Similar substrate recognition motifs for mammalian Amp-activated protein kinase, higher-plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 361, 191\u2013195 (1995).","journal-title":"FEBS Lett."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3821","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:49:41Z","timestamp":1684450181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFnm3821"],"URL":"https:\/\/doi.org\/10.1038\/nm.3821","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,6]]},"assertion":[{"value":"14 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}